Summary
Effects of nonchelating and chelating agents at 10 mM on the serum-free culture of rat dermal fibroblasts were investigated. A strong iron-chelating agent, iminodiacetic acid (IDA), and a weak one, dihydroxyethylglycine (DHEG), decreased iron permeation into preconfluent fibroblasts. A weak iron-chelating agent, glycylglycine (GG), a nonchelating agent, N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid (HEPES), and human apotransferrin (10 µg/ml) increased the permeation with time. Iron may be essential for survival of fibroblasts because subconfluent fibroblasts exposed to 100 µM FeSO4 in combination with transferrin, HEPES, or GG significantly decreased to release lactate dehydrogenase into the medium. Superoxide dismutase and dimethyl sulfoxide blocked the enzyme release, suggesting that superoxide and hydroxyl radical induce cellular damage but hydrogen peroxide (H2O2) generated by superoxide dismutation does not. GG significantly reduced H2O2 cytotoxicity. DHEG acted as a potent promoter of the iron-stimulated cellular damage if ascorbate or H2O2 was added to the medium. FeSO4 and FeCl3 (50 to 100 µM) individually combined with IDA maximally promoted fibroblast proliferation. Ascorbate increased formation of thiobarbituric acid-reactive substances from deoxyribose in the medium supplemented with FeSO4 and either IDA or DHEG. Conversely, ascorbate decreased the formation in the medium with FeSO4 and with or without other agents. Fibroblast proliferation may thus be stimulated through the active oxygen generation mediated by a redox-cycling between Fe3+ and Fe2+, which are dissolved in the medium at a high concentration, rather than through delivery of iron into the cells.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Aasa, R.; Aisen, P. An electron paramagnetic resonance study of the iron and copper complexes of transferrin. J. Biol. Chem. 243:2399–2404; 1968.
Aruoma, O. I.; Halliwell, B. Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Are lactoferrin and transferrin promoters of hydroxyl-radical generation? Biochem. J. 241:273–278; 1987.
Aruoma, O. I.; Halliwell, B.; Gajewski, E., et al. Copper-ion-dependent damage to the bases in DNA in the presence of hydrogen peroxide. Biochem. J. 273:601–604; 1991.
Aust, S. D.; Morehouse, L. A.; Thomas, C. E. The role of transition metals in oxygen radical reactions. J. Free Radic. Biol. Med. 1:3–25; 1985.
Balin, A. K.; Goodman, D. B. P.; Rasmussen, H., et al. The effect of oxygen and vitamin E on the lifespan of human diploid cells in vitro. J. Cell Biol. 74:58–67; 1977.
Brieland, J. K.; Clarke, S. J.; Karmiol, S., et al. Transferrin: a potential source of iron for oxygen free radical-mediated endothelial cell injury. Arch. Biochem. Biophys. 294:265–270; 1992.
Breimer, L. H. Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage. Mol. Carcinog. 3:188–197; 1990.
Chance, B.; Sies, H.; Boveris, A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59:527–605; 1979.
Esterbauer, H.; Cheeseman, K. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 86:407–421; 1990.
Fridovich, I. Superoxide dismutases. Annu. Rev. Biochem. 44:147–159; 1975.
Fridovich, I. The biology of oxygen radicals. Science 201:875–880; 1978.
Fujimoto, S.; Kawakami, N.; Ohara, A. Nonenzymatic glycation of transferrin: decrease of iron-binding capacity and increase of oxygen radical production. Biol. Pharm. Bull. 18:396–400; 1995.
Gutteridge, J. M. C.; Quinlan, G. J. Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteins. Biochim. Biophys. Acta 1156:144–150; 1993.
Gutteridge, J. M. C.; Richmond, R.; Halliwell, B. Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and lipid peroxidation by desferrioxamine. Biochem. J. 184:469–472; 1979.
Halliwell, B.; Gutteridge, J. M. C. Formation of thiobarbituric-acid-reactive substance from deoxyribose in the presence of iron salts: the role of superoxide and hydroxyl radicals. FEBS Lett. 128:347–352; 1981.
Halliwell, B.; Gutteridge, J. M. C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219:1–14; 1984.
Hamilton, K. O.; Stallibrass, L.; Hassan, I., et al. The transport of two iron chelators, desferrioxamine B and L1, across Caco-2 monolayers. Br. J. Haematol. 86:851–857; 1994.
Harman, D. The aging process. Proc. Natl. Acad. Sci. USA 78:7124–7128; 1981.
Horton, A. A.; Fairhurst, S. Lipid peroxidation and mechanisms of toxicity. Crit. Rev. Toxicol. 18:27–79; 1987.
Kann, H. E., Jr.; Mengel, C. E.; Clancy, W. T., et al. Effects of in vivo hyperoxia on erythrocytes. VI. Hemolysis occurring after exposure to oxygen under high pressure. J. Lab. Clin. Med. 70:150–157; 1967.
Keyse, S. M.; Tyrrell, R. M. Heme oxygenase is the major 32-KDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc. Natl. Acad. Sci. USA 86:99–103; 1989.
Knight, J. A.; Blaylock, R. C.; Searles, D. A. Lipid peroxidation in platelet concentrates: effects of irradiation and metal chelators. Ann. Clin. Lab. Sci. 23:333–339; 1993.
Kozlov, A. B.; Ostrachovitch, E. A.; Afanas’ev, I. B. Mechanism of inhibitory effects of chelating drugs on lipid peroxidation in rat brain homogenates. Biochem. Pharmacol. 47:795–799; 1994.
Kukielka, E.; Cederbaum, A. I. Ferritin stimulation of hydroxyl radical production by rat liver nuclei. Arch. Biochem. Biophys. 308:70–77; 1994.
Lowry, O. H.; Rosebrough, N. J.; Farr, A. L., et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275; 1951.
Lu, D.; Maulik, N.; Moraru, I. I., et al. Molecular adaptation of vascular endothelial cells to oxidative stress. Am. J. Physiol. 264:C715-C722; 1993.
Medzon, E. L.; Gedies, A. Substitution of 4-(2-hydroxyethyl)-1-piperazineethane sulfonic acid (HEPES) for bicarbonate in protein-free animal cell culture medium: application to vaccinia virus quantitation and fluorogenic acetylesterase assay in living LM cells. Can. J. Microbiol. 17:651–653; 1971.
Miller, R. A.; Britigan, B. E. Protease-cleaved iron-transferrin augments oxidant-mediated endothelial cell injury via hydroxyl radical formation. J. Clin. Invest. 95:2491–2500; 1995.
Morrison, A. R.; Winokur, T. S.; Brown, W. A. Inhibition of soybean lipoxygenase by mannitol. Biochem. Biophys. Res. Commun. 108:1757–1762; 1982.
Morgan, E. H. Studies on the mechanism of iron release from transferrin. Biochim. Biophys. Acta 580:312–326; 1979.
Murrell, G.; Francis, N.; Bromley, L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem. J. 265:659–665; 1990.
O’Donnell-Tormey, J.; Nathan, C. F.; Lanks, K., et al. Secretion of pyruvate. An antioxidant defense of mammalian cells. J. Exp. Med. 165:500–514; 1987.
Pacifici, R. E.; Davies, K. J. A. Protein, lipid and DNA repair systems in oxidative stress: the free-radical theory of aging revisited. Gerontology 37:166–180; 1991.
Pantopoulos, K.; Hentze, M. W. Rapid responses to oxidative stress mediated by iron regulatory protein. EMBO J. 14:2917–2924; 1995.
Pasantes-Morales, H.; Murray, R. A.; Sanchez-Olea, R., et al. Regulatory volume decrease in cultured astrocytes. II. Permeability pathway to amino acids and polyols. Am. J. Physiol. 266:C172-C178; 1994.
Sawada, M.; Carlson, J. C. Changes in superoxide radical and lipid peroxide formation in the brain, heart and liver during the lifetime of the rat. Mech. Ageing Dev. 41:125–137; 1987.
Shipman, C., Jr. Evaluation of 4-(2-hydroxyethyl)-l-piperazineethane-sulfonic acid (HEPES) as a tissue culture buffer. Proc. Soc. Exp. Biol. Med. 130:305–310; 1969.
Spiro, T. G.; Allerton, S. E.; Renner, J., et al. The hydrolytic polymerization of iron(III). J. Am. Chem. Soc. 88:2721–2726; 1966.
Steiner, M. G.; Babbs, C. F. Hydroxyl radical generation by postischemic rat kidney slices in vitro. Free Radic. Biol. Med. 9:67–77; 1990.
Stocker, R.; Glazer, A. N.; Ames, B. N. Antioxidant activity of albumin-bound bilirubin. Proc. Natl. Acad. Sci. USA 84:5918–5922; 1987.
Trush, M. A.; Kensler, T. W. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radic. Biol. Med. 10:201–209; 1991.
Wayner, D.; Burton, G.; Ingold, K., et al. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochem. Biophys. Acta 924:408–419; 1987.
Williams, A.; Pugh, A.; Hoy, T. G., et al. Screening for iron chelating drugs. In: Saltman, P.; Hegenauer, J., ed. The biochemistry and physiology of iron. Amsterdam: Elsevier North Holland, Inc.; 1982:199–204.
Yabe, N.; Kato, M.; Matsuya, Y., et al. Role of iron chelators in growth-promoting effect on mouse hybridoma cells in a chemically defined medium. In Vitro Cell. Dev. Biol. 23:815–820; 1987.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yabe, N., Matsui, H. Effects of iron chelates on the transferrin-free culture of rat dermal fibroblasts through active oxygen generation. In Vitro Cell.Dev.Biol.-Animal 33, 527–535 (1997). https://doi.org/10.1007/s11626-997-0095-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11626-997-0095-1